FDA/CDC

FDA wants data on role of flavored tobacco products in youth initiation


 

The Food and Drug Administration is seeking data on the role that flavors, including menthol, in tobacco products play in the initiation, use, and cessation of tobacco products, with an emphasis on how flavoring impacts young people.

“In the spirit of our commitment to preventing kids from using tobacco, we are taking a closer look at flavors in tobacco products to better understand their level of impact on youth initiation,” FDA Commissioner Scott Gottlieb, MD, said in statement. It is important “that we also explore how flavors, under a properly regulated framework that protects youth, may also be helping some currently addicted adult cigarette smokers switch to certain noncombustible forms of tobacco products.”

ecigarette teenager Thinkstockphotos.com
The agency issued an advance notice of proposed rule making March 20 that seeks information on flavoring in tobacco products to inform future policy making.

“Youth consistently report product flavoring as a leading reason for using tobacco products,” Dr. Gottlieb noted. “In fact, there is evidence indicating that youth tobacco users who reported their first tobacco was flavored had a higher prevalence of current tobacco product use, compared to youth whose product was not flavored.”

Pages

Recommended Reading

Flu activity takes another turn for the better
MDedge Pediatrics
Climate change is worsening allergies, expert says
MDedge Pediatrics
Peanut is most prevalent culprit in anaphylaxis PICU admits
MDedge Pediatrics
Flu activity continues to decline
MDedge Pediatrics
Unassigned school epinephrine used more than assigned injectors
MDedge Pediatrics
Swamp coolers not linked to dust mite sensitization in atopic children
MDedge Pediatrics
New approaches needed for food allergies in minority children
MDedge Pediatrics
MDedge Daily News: Could gut bacteria trigger autoimmune diseases?
MDedge Pediatrics
FDA proposes lower nicotine levels in cigarettes
MDedge Pediatrics
Switch to mepolizumab safe in eosinophilic asthma
MDedge Pediatrics